EGFR and cancer: Our analysis identified several driver PPI interfaces in known cancer driver genes, such as TP53, HRAS, PIK3CA or EGFR, proving that our method can find relevant genes and that alteration of interaction interfaces is a common pathogenic mechanism of cancer somatic mutations.